Clinical Trial

Hydroxychloroquine Sulfate Tablets for Radiation-induced Oral Mucositis

Study acronym: RIOM
Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated April 29, 2025 (before its estimated June 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Evaluate the safety, tolerance and efficacy of hydroxychloroquine sulfate tablets the prevention and treatment of oral mucositis and dysgeusia in patients undergoing radiotherapy
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-20; most recent amendment 2025-04-26.
Status change: Not Yet Recruiting → Recruiting 2025-04-23
Trial Details
NCT Number NCT06939582
Lead Sponsor Xingchen Peng
Conditions Radiation-induced Oral Mucositis
Enrollment 158 participants
Start Date 2024-12-22
Primary Completion 2025-06-01 (estimated)
Study Completion 2025-06-20 (estimated)
Updated on ClinicalTrials.gov 2025-04-29